Search results
Brokerage maintains buy on AstraZeneca shares, sees growth potential By Investing.com
Investing.com· 17 hours agoOn Friday, TD Cowen affirmed its positive stance on AstraZeneca (NASDAQ:AZN), maintaining a Buy...
Deutsche Bank maintains 'Hold' on AstraZeneca post ASCO conference By Investing.com
Investing.com· 3 days agoOn Monday, Deutsche Bank (ETR:DBKGn) reiterated a Hold rating and a price target of GBP110.00 on...
AstraZeneca Buy rating, stock target reiterated on consistent presence By Investing.com
Investing.com· 3 days agoOn Wednesday, Citi reaffirmed its Buy rating on AstraZeneca (NASDAQ:AZN) shares with a steady price...
AstraZeneca completes acquisition of biopharma company Fusion Pharma
dpa international via Yahoo Finance· 3 days agoBritish pharmaceutical company AstraZeneca on Wednesday announced the completion of the acquisition...
AstraZeneca completes Fusion Pharmaceuticals acquisition
Pharmaceutical Technology via Yahoo Finance· 3 days agoAstraZeneca has announced the conclusion of its acquisition of clinical-stage biopharmaceutical...
3 No-Brainer Stocks to Buy in June
Motley Fool via Yahoo Finance· 6 days agoBut what does June bring? Three Motley Fool contributors think the new month should usher in great investing opportunities. Here's why they picked AbbVie...
Healthy Returns: Drugmakers release promising cancer drug data – and AstraZeneca wins big
CNBC· 18 hours agoPatients with musculoskeletal conditions who like to stay in their pajamas received some welcome...
First Trust Advisors LP Raises Stock Position in AstraZeneca PLC (NASDAQ:AZN)
ETF DAILY NEWS· 2 days agoFirst Trust Advisors LP grew its holdings in AstraZeneca PLC (NASDAQ:AZN – Free Report) by 7.4% in the fourth quarter, according to its most recent filing with the Securities ...
Astrazeneca (AZN) Beats Stock Market Upswing: What Investors Need to Know
Zacks via Yahoo Finance· 4 days agoAstrazeneca (AZN) closed the most recent trading day at $78.99, moving +1.24% from the previous...
Data Science Hiring Process at AstraZeneca
Analytics India Magazine· 3 days agoWith over 45 years of presence in India, British-Swedish pharmaceutical and biotechnology giant AstraZeneca has data science and AI capabilities deeply ingrained across its ...